Tumor profiling has transformed brain cancer research by identifying key biomarkers like CD133, nestin, and UCH-L1, offering insights into tumor heterogeneity, progression, and resistance. Despite challenges like the blood-brain barrier, Creative Biolabs overcame these with multi-omics integration and constructed our Tumor Profiling to Guide Targeted Cancer Therapy Platforms. Our services empower researchers to make informed decisions, driving innovation in brain cancer research. |
Assunto anterior
Primeira 